| Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact L Li, Y Wei, C To, CQ Zhu, J Tong, NA Pham, P Taylor, V Ignatchenko, ... Nature communications 5, 5469, 2014 | 125 | 2014 |
| Comprehensive proteome analysis of fresh frozen and optimal cutting temperature (OCT) embedded primary non-small cell lung carcinoma by LC–MS/MS W Zhang, S Sakashita, P Taylor, MS Tsao, MF Moran Methods 81, 50-55, 2015 | 43 | 2015 |
| Proteomic profiles of human lung adeno and squamous cell carcinoma using super‐SILAC and label‐free quantification approaches W Zhang, Y Wei, V Ignatchenko, L Li, S Sakashita, NA Pham, P Taylor, ... Proteomics 14 (6), 795-803, 2014 | 40 | 2014 |
| Cancer proteome and metabolite changes linked to SHMT2 J Tong, JR Krieger, P Taylor, R Bagshaw, J Kang, S Jeedigunta, ... PloS one 15 (9), e0237981, 2020 | 20 | 2020 |
| Differential regulation of FGFR3 by PTPN1 and PTPN2 JR St‐Germain, P Taylor, W Zhang, Z Li, T Ketela, J Moffat, BG Neel, ... Proteomics 15 (2-3), 419-433, 2015 | 15 | 2015 |
| Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non–Small Cell Lung Cancer S Mirhadi, W Zhang, NA Pham, F Karimzadeh, M Pintilie, J Tong, P Taylor, ... Molecular Cancer Research 21 (1), 36-50, 2023 | 13 | 2023 |
| Design and evaluation of ZD06519, a novel camptothecin payload for antibody drug conjugates ME Petersen, MG Brant, M Lasalle, S Das, R Duan, J Wong, T Ding, ... Molecular Cancer Therapeutics 23 (5), 606-618, 2024 | 8 | 2024 |
| Proteomic characterization of a candidate polygenic driver of metabolism in non-small cell lung cancer H Badr, R Blutrich, K Chan, J Tong, P Taylor, W Zhang, R Kafri, HL Röst, ... Journal of Molecular Biology 434 (13), 167636, 2022 | 7 | 2022 |
| Abstract B32: Fidelity of genomic and proteomic features of patient-derived xenografts of lung cancers NA Pham, D Wang, J Tong, CQ Zhu, L Li, W Zhang, R Shi, S Sakashita, ... Clinical Cancer Research 22 (16_Supplement), B32-B32, 2016 | 1 | 2016 |
| PUB052 Proteome Signatures and New Cancer Drivers W Zhang, S Sakashita, M Pintilie, B Pitcher, J Tong, P Taylor, NA Pham, ... Journal of Thoracic Oncology 12 (1), S1478, 2017 | | 2017 |
| Proteome Signatures with Prognostic Impact Distinguish Non-Small Cell Lung Cancer Histology Subtypes and Metabolic States W Zhang, S Sakashita, P Taylor, J Tong, NA Pham, V Ignatchenko, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S719-S719, 2015 | | 2015 |
| Proteome signatures distinguish lung cancer subtypes, define metabolism states, and have prognostic impact W Zhang, P Taylor, L Li, Y Wei, J Tong, V Ignatchenko, NA Pham, ... Cancer Research 75 (15_Supplement), 1822-1822, 2015 | | 2015 |
| Abstract SY33-04: Integrated omic analysis of lung cancer reveals metabolism-proteome signatures with prognostic impact MF Moran, L Li, Y Wei, P Taylor, C To, J Tong, V Ignatchenko, M Pintilie, ... Cancer Research 75 (15_Supplement), SY33-04-SY33-04, 2015 | | 2015 |
